Physician profile
Manuel Areces
NPI 1740294008
$3,832.37
in general payments reported to CMS, 2019-2025
20 companies · $476 in 2025
The $476 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $700 · 2021: $719 · 2022: $434 · 2023: $316 · 2024: $402 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.39 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $518.32 | 2019-2020 | |
| Medtronic, INC. | $515.21 | 2021-2025 | Corevalve Evolut R, Harmony, Linq II |
| Abbott Laboratories | $472.08 | 2019-2025 | Xience Skypoint, Mitraclip, Ultreon |
| Edwards Lifesciences Corporation | $412.64 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $348.24 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $306.82 | 2019-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $290.32 | 2019-2025 | Jardiance |
| Pbg Puerto Rico LLC | $226.67 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $144.16 | 2020-2022 | |
| Chiesi USA, INC. | $125.01 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $98.99 | 2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $87.81 | 2022-2025 | Winrevair, Verquvo, Capvaxive |
| Amgen INC. | $82.72 | 2020-2021 | |
| Asahi Intecc USA, INC. | $53.04 | 2023 | Asahi Ptca Guide Wire |
| Scpharmaceuticals INC. | $41.67 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $25.10 | 2020 | |
| Boston Scientific Corporation | $24.92 | 2021 | |
| Pfizer Pharmaceuticals LLC | $20.00 | 2019 | |
| Terumo Medical Corporation | $19.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Areces listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.